IL2 and neoplasm: As well as mediating adaptive immune functions, IL-12 has angiostatic effects (Duda et al, 2000), and histological evaluation of tumours from mice treated with Neuro-IL2/IL12 or AJ-IL2/IL12 vaccines suggested that the vascularisation was reduced compared to control tumours.